Gara Jalqabaatti › Meningioma
Qorannoo klinikaalii Meningioma Ameerikaa Keessatti hirmaatuu
Qorannoo 28 Meningioma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- New York City, NYQorannoo 8
- Miami, FLQorannoo 7
- Columbus, OHQorannoo 6
- Boston, MAQorannoo 6
- Jacksonville, FLQorannoo 5
- San Francisco, CAQorannoo 5
- Atlanta, GAQorannoo 5
- San Diego, CAQorannoo 5
- Phoenix, AZQorannoo 4
- Houston, TXQorannoo 4
- Arlington, VAQorannoo 4
- Detroit, MIQorannoo 4
- Durham, NCQorannoo 3
- St. Louis, MOQorannoo 3
- Los Angeles, CAQorannoo 3
- Omaha, NEQorannoo 3
- Cedar Rapids, IAQorannoo 3
- Cincinnati, OHQorannoo 3
- Baltimore, MDQorannoo 3
- Seattle, WAQorannoo 3
- Tampa, FLQorannoo 3
- Milwaukee, WIQorannoo 3
- Nashville, TNQorannoo 3
Naannoon
- ArizonaQorannoo 4
- CaliforniaQorannoo 12
- FloridaQorannoo 7
- GeorgiaQorannoo 5
- IndianaQorannoo 3
- IowaQorannoo 3
- KentuckyQorannoo 3
- MarylandQorannoo 5
- MassachusettsQorannoo 6
- MichiganQorannoo 4
- MinnesotaQorannoo 4
- MissouriQorannoo 3
- NebraskaQorannoo 3
- New HampshireQorannoo 3
- New YorkQorannoo 9
- North CarolinaQorannoo 5
- OhioQorannoo 7
- PennsylvaniaQorannoo 3
- TennesseeQorannoo 4
- TexasQorannoo 4
- VirginiaQorannoo 4
- WashingtonQorannoo 3
- WisconsinQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06955169Natural History Study of Patients With Neurofibromatosis Type 2
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 8 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT00598351A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07428616UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT04343157Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT04374305Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06557512Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06014905RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT07150806A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07533942Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT04427384Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 4 hanga 39 · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT05278208Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT07493447Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT05576103Cognitive Status After Removal of Skull Base Meningioma
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 89 · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT04635657Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT07418775Cabozantinib for Patients With Recurrent or Progressive Meningioma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Cam-2026 · NCT05425004Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 14-Cam-2026 · NCT05636618Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Elb-2026 · NCT04082520Abemaciclib in Newly Diagnosed Meningioma Patients
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05940493Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 27-Gur-2026 · NCT06377371Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT04278118Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Gur-2026 · NCT06132685Evaluation of the CONVIVO System
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Gur-2026 · NCT05139277Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Gur-2026 · NCT06650163Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.